From Mdwiki - Reading time: 9 min| Names | |
|---|---|
| Trade names | Disalcid, Salflex, other |
| Other names | Salicylsalicylic acid, sodium salicylate |
| |
| Clinical data | |
| Drug class | NSAID (salicylate)[1] |
| Main uses | Inflammation[1] |
| Side effects | Ringing in the ears, nausea, rash, Reye syndrome, stomach bleeding, kidney problems, anaphylaxis[1] |
| Pregnancy category |
|
| Typical dose | 1 to 1.5 gram[1] |
| External links | |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a682880 |
| Legal | |
| Legal status |
|
| Chemical and physical data | |
| Formula | C14H10O5 |
| Molar mass | 258.229 g·mol−1 |
Salsalate, sold under the brand name Disalcid among others, is a medication used to treat inflammation in conditions such as rheumatoid arthritis.[1] It is taken by mouth.[1]
Common side effects include ringing in the ears, nausea, and rash.[1] Other side effects may include Reye syndrome, stomach bleeding, kidney problems, liver problems, and anaphylaxis.[1] Use in the later part of pregnancy may harm the baby.[1] It is a nonsteroidal anti-inflammatory drug (NSAID) of the salicylate type and blocks both COX-1 and COX-2.[1]
Salsalate was introduced in the 1960s.[2] It is available as a generic medication.[3] In the United States 60 tablets of 750 mg costs about 25 USD as of 2021.[3]
Salsalate may be used for inflammatory disorders such as rheumatoid arthritis or noninflammatory disorders such as osteoarthritis.[4][5]
The typical dose is 1,000 mg three time per day or 1,500 mg twice per day.[1]
The risk of bleeding is a common concern with use of the NSAID class of medications. However, the bleeding risk associated with salsalate is lower than that associated with aspirin use.[6]
Relative to other NSAIDs, salsalate has a weak inhibitory effect on the cyclooxygenase enzyme and decreases the production of several proinflammatory chemical signals such as interleukin-6, TNF-alpha, and C-reactive protein.[4]
The mechanism through which salsalate is thought to reduce the production of these inflammatory chemical signals is through the inhibition of IκB kinase resulting in decreased action of NF-κB genes.[4][6][7] This mechanism is thought to be responsible for salsalate's insulin-sensitizing and blood sugar lowering properties.[6]
Salsalate had been suggested as possible treatment for diabetes as early as 1876.[4][8][9]
Salsalate is the generic name of a prescription medication marketed under the brandnames Mono-Gesic, Salflex, Disalcid, and Salsitab. Other generic and brand name formulations may be available.[10]

Salsalate has been proposed for the prevention and treatment of type 2 diabetes due to its ability to lower insulin resistance associated with inflammation and may be useful in prediabetes.[4] However, the use of salsalate to prevent the progression from prediabetes to type 2 diabetes mellitus has received limited study.[4]
| Identifiers: |
|
|---|